Podcast

Managing Early-Stage HER2-Positive Breast Cancer

Author(s):

OncLive Staff

In the second segment, Dr Mahtani and colleagues discuss data from select clinical trials in the neoadjuvant and adjuvant settings for patients with HER2-positive breast cancer.

Newsletter

Stay up to date on the most recent and practice-changing oncology data

Subscribe Now!

Latest CME

View All
Tumor Board: Expert Insights on Managing Classical 𝘌𝘎𝘍𝘙 Mutations, 𝘌𝘎𝘍𝘙 Exon 20 Insertions, and Atypical 𝘌𝘎𝘍𝘙 Mutations in Metastatic NSCLC
Video

Tumor Board: Expert Insights on Managing Classical 𝘌𝘎𝘍𝘙 Mutations, 𝘌𝘎𝘍𝘙 Exon 20 Insertions, and Atypical 𝘌𝘎𝘍𝘙 Mutations in Metastatic NSCLC

Jun 6th 2025 - Jul 12th 2025

online-activity
View More
Medical Crossfire®: Expert Perspectives on Targeting c-Met Overexpression and 𝘔𝘌𝘛 Genomic Alterations in NSCLC – Unveiling the Complexities of 𝘔𝘌𝘛 Dysregulation
Video

Medical Crossfire®: Expert Perspectives on Targeting c-Met Overexpression and 𝘔𝘌𝘛 Genomic Alterations in NSCLC – Unveiling the Complexities of 𝘔𝘌𝘛 Dysregulation

Jun 6th 2025 - Jul 12th 2025

online-activity
View More
Evolving Treatment Strategies in Pancreatic Cancer: Current Standards, Emerging Targets, and the Role of Molecular Testing
Video

Evolving Treatment Strategies in Pancreatic Cancer: Current Standards, Emerging Targets, and the Role of Molecular Testing

Jun 5th 2025 - Jul 12th 2025

online-activity
View More
Related Content
The top 5 OncLive videos of the week cover insights in non–small cell lung cancer, small cell lung cancer, and breast cancer.
June 15th 2025

Five Under 5: Top Oncology Videos for the Week of 6/8

Kate Gasparini, PharmD, BCOP, BCPPS, pediatric oncology clinical pharmacy specialist, Memorial Sloan Kettering Cancer Center
June 17th 2025

Liquid Imatinib Formulation Expands Leukemia Treatment Options and Improves Treatment Adherence: With Kate Gasparini, PharmD, BCOP, BCPPS

Breast Cancer | Image Credit: © Sebastian Kaulitzki - stock.adobe.com
June 11th 2025

The Role of Liquid Biopsies in Precision Approaches for Breast Cancer Therapy

The Expanding Role of AR Inhibition in mHSPC Management: With Alicia Morgans, MD, MPH
June 16th 2025

The Expanding Role of AR Inhibition in mHSPC Management: With Alicia Morgans, MD, MPH

Elacestrant Combinations in ER+ Breast Cancer | Image Credit: © Sebastian Kaulitzki - stock.adobe.com
June 10th 2025

Elacestrant Displays Potential as Combination Backbone in ER+ Breast Cancer After CDK4/6 Inhibition

Five Under 5: Top Oncology Videos for the Week of 6/1
June 8th 2025

Five Under 5: Top Oncology Videos for the Week of 6/1